You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pibrentasvir

Showing 1 - 25 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ptsd Trial in White River Junction (Glecaprevir / Pibrentasvir Pill)

Not yet recruiting
  • Ptsd
  • Glecaprevir / Pibrentasvir Pill
  • White River Junction, Vermont
    White River Junction VAMC
Dec 12, 2022

Ptsd Trial in White River Junction (Glecaprevir/pibrentasvir, Placebo)

Not yet recruiting
  • Ptsd
  • White River Junction, Vermont
    White River Junction VAMC
Dec 12, 2022

ESRD Trial in New York (Glecaprevir/pibrentasvir)

Enrolling by invitation
  • ESRD
  • New York, New York
    NYU Langone Health
Aug 5, 2022

Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

Recruiting
  • Hepatitis C
  • Sofosbuvir 400mg [Sovaldi]
  • Glecaprevir/pibrentasvir (300mg/120mg)
  • Darlinghurst, New South Wales, Australia
  • +2 more
Mar 28, 2022

Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin

Recruiting
  • Hepatitis C Infection
  • HIV Infection
  • Glecaprevir/Pibrentasvir (G/P)
  • Ribavirin (RBV)
  • San Diego, California
  • +15 more
Dec 19, 2022

End Stage Renal Disease, Hepatitis C Trial in Baltimore (Glecaprevir/pibrentasvir)

Active, not recruiting
  • End Stage Renal Disease
  • Hepatitis C
  • Baltimore, Maryland
    Johns Hopkins Hospital
Dec 7, 2021

Oral Glecaprevir/Pibrentasvir Tablet In Pediatric And Adult

Completed
  • Hepatitis C Virus (HCV)
    • Chelyabinsk, Russian Federation
    • +5 more
    Jun 8, 2022

    Glecaprevir/Pibrentasvir in Chronic Hepatitis C Genotypes 1 to 6

    Completed
    • Hepatitis C Virus (HCV)
      • Makhachkala, Dagestan, Respublika, Russian Federation
      • +7 more
      Jun 23, 2022

      Kidney Failure, Hepatitis C, Kidney Disease, Chronic Trial in Boston (Glecaprevir and Pibrentasvir)

      Recruiting
      • Kidney Failure
      • +2 more
      • Glecaprevir and Pibrentasvir
      • Boston, Massachusetts
        Massachusetts General Hospital
      Jun 4, 2021

      Hepatitis C Trial in Long Island City, New York (diagnostic test, other, drug)

      Recruiting
      • Hepatitis C
      • Cepheid POC HCV Viremia (RNA) test
      • +2 more
      • Long Island City, New York
      • +2 more
      Dec 20, 2022

      Cardiovascular Diseases, Hepatitis C, Hiv Trial in Washington, Baltimore (Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac

      Active, not recruiting
      • Cardiovascular Diseases
      • +2 more
      • Elbasvir / Grazoprevir Oral Tablet [Zepatier]
      • Cardiac MRI
      • Washington, District of Columbia
      • +1 more
      Feb 1, 2023

      Hepatitis C, Liver Inflammation, Liver Cirrhoses Trial in Australia (Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet,

      Recruiting
      • Hepatitis C
      • +2 more
      • Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
      • Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
      • Randwick, New South Wales, Australia
      • +6 more
      Mar 28, 2022

      Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

      Completed
      Has Results
      • Hepatitis C Virus (HCV)
      • Glecaprevir/pibrentasvir adult formulation
      • Glecaprevir/pibrentasvir pediatric formulation
      • San Francisco, California
      • +37 more
      Sep 19, 2022

      Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

      Completed
      Has Results
      • Chronic Hepatitis C
      • +2 more
      • (no location specified)
      Jul 9, 2021

      Renal Failure Chronic, Hepatitis C Trial in United States (glecaprevir/pibrentasvir treatment)

      Completed
      Has Results
      • Renal Failure Chronic
      • Hepatitis C
      • glecaprevir/pibrentasvir treatment
      • Chicago, Illinois
      • +6 more
      Jan 18, 2022

      Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of Trial in San Diego (glecaprevir/pibrentasvir (GLE/PIB))

      Completed
      • Hepatitis C
      • Hepatitis C Virus Infection, Response to Therapy of
      • glecaprevir/pibrentasvir (GLE/PIB)
      • San Diego, California
        University of California San Diego
      May 23, 2022

      Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12

      Active, not recruiting
      • Hepatitis C Virus (HCV)
        • Chelyabinsk, Russian Federation
        • +9 more
        Mar 1, 2022

        Hepatitis C Trial in Sydney (HCV RNA Point of Care, Sofosbuvir/velpatasvir, Glecaprevir/pibrentasvir)

        Recruiting
        • Hepatitis C
        • HCV RNA Point of Care
        • +2 more
        • Sydney, New South Wales, Australia
          NUAA NSP
        Aug 19, 2022

        End Stage Renal Disease, Hepatitis C Trial in Baltimore (300mg glecaprevir/pibrentasivir 120mg)

        Completed
        Has Results
        • End Stage Renal Disease
        • Hepatitis C
        • 300mg glecaprevir/pibrentasivir 120mg
        • Baltimore, Maryland
          Johns Hopkins University
        Sep 21, 2021

        Hepatitis C, Kidney Transplant; Complications, Heart Transplant Infection Trial in Scottsdale (Mavyret)

        Active, not recruiting
        • Hepatitis C
        • +2 more
        • Scottsdale, Arizona
          Mayo Clinic in Arizona
        Mar 4, 2022

        Clinical Practice Use of Glecaprevir Plus Pibrentasvir in

        Completed
        • Chronic Hepatitis C (CHC)
          • Samara, Samarskaya Oblast, Russian Federation
          • +8 more
          Aug 25, 2021

          Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

          Completed
          Has Results
          • Chronic Hepatitis C Virus
          • Hepatitis C Virus
          • (no location specified)
          Jul 14, 2021

          Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, OBV/PTV/r)

          Completed
          Has Results
          • Chronic Hepatitis C Virus
          • Hepatitis C Virus
          • (no location specified)
          Jul 14, 2021

          End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])

          Withdrawn
          • End Stage Renal Disease
          • Chronic Hepatitis c
          • Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
          • Boston, Massachusetts
            Massachusetts General Hospital
          Mar 4, 2022

          Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

          Completed
          Has Results
          • Chronic Hepatitis C
          • Hepatitis C Virus
          • (no location specified)
          Jul 9, 2021